MedPath

A clinical trial to study the effects of two different dressings, honey dressing and betadine dressing in patients with diabetic foot ulcer

Phase 3
Conditions
Health Condition 1: null- DIABETIC FOOT ULCER PATIENTS
Registration Number
CTRI/2015/01/005457
Lead Sponsor
Manipal university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Patient voluntarily willing to participate and give written informed consent, to comply with all study requirements

Patient with Known or newly diagnosed diabetes mellitus confirmed by ADA 2013 criteria

Patients with non healing ulcer of Wagner Classification grade 1 and 2 for atleast 2 weeks

Patients willing to follow up and complete treatment

Patient who does not require frequent debridement.( frequent debridement is defined as >1 debridement a ulcer per week )

Exclusion Criteria

Acute wound less than 2 weeks duration.

Patients with ulcer (Wagner classification 3,4 and 5

Patient with cellulitis or abscess.

Fasting plasma glucose, more than 240mg/dl at the time of recruitment

Renal disease needing hemodialysis or transplantation

Hepatic disease with elevated transaminases > 2.5 times the upper limit of normal or bilirubin > 2 mg/dl

congestive cardiac failure with NYHA class III and IV

Patient with active MRSA, VRE, Streptococcal infection.

Patients on i.v antibiotics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PERCENTAGE REDUCTION IN ULCER SIZE AFTER 6 WEEKS OF DRESSINGTimepoint: 6week
Secondary Outcome Measures
NameTimeMethod
â?¢Incidence of adverse events <br/ ><br>â?¢Proportion of participants with completely healed wound <br/ ><br>â?¢Proportion of participants with Microbiological clearance. <br/ ><br>â?¢Incidence of super infection <br/ ><br>â?¢Length of hospital stay <br/ ><br>â?¢Time of appearance of healthy granulated tissue <br/ ><br>â?¢Number of debridement required <br/ ><br>â?¢Effect on exudate and malador <br/ ><br>Timepoint: baseline and then every week upto 6 week
© Copyright 2025. All Rights Reserved by MedPath